Free Virtual Consultations. Corona Virus Related Cases Click Here.

Woman Killed in Pedestrian Crash at Kerr Avenue and Yosemite Boulevard

Victim Killed in Fatal Modesto Accident

Modesto, CA (March 31, 2020) – A woman was killed in a pedestrian crash in Modesto. The fatal accident occurred on the afternoon of March 31 at Kerr Avenue and Yosemite Boulevard.

The woman was walking in the intersection when she was hit by a GMC Yukon that was turning left. The woman was taken to a local hospital, where she later died. The driver of the Yukon remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.



May 5, 2020

3 Injured in Crash at Golden State Boulevard and Manning Avenue

Multiple Vehicles Involved in Fowler Accident...

December 12, 2019

2 Injured in Crash on Walker Street

Students Hit by Van in Watsonville Accident...

October 10, 2019

Crash on Highway 50 Near Stockton Boulevard Causes Minor Injuries

3 Vehicles Involved in Sacramento Accident Sacramento, CA (October 9, 2019) –...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.